Application of a Protocol of Personalyzed Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insulin in Routine Clincal Care
Conditions: Type 2 Diabetes Mellitus; Multiple Dose Insulin Therapy Interventions: Other: Personalized treatment Sponsors: Hospital Arnau de Vilanova; Institut Catala de Salut Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Interventions: Drug: HEC88473, Placebo, Dulaglutide Sponsors: Dongguan HEC Biopharmaceutical R&D Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
The ACCT2 Study Individuals With Type 2 Diabetes and Non-Western Backgrounds (ACCT2)
Conditions: Type 2 Diabetes Interventions: Behavioral: Person-centred culturally sensitive course of treatment Sponsors: Steno Diabetes Center Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Time Spent In Target Glucose Range in Women With T2D Diabetes in Pregnancy
Conditions: Diabete Type 2; Pregnancy in Diabetic Interventions: Device: Dexcom Continuous Glucose Monitoring Sponsors: Mount Sinai Hospital, Canada; University of Manitoba; Women ' s College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
A Person-centred and Culturally Sensitive Course of Treatment Targeting Individuals With Type 2 Diabetes and Non-Western Backgrounds (ACCT2)
Conditions: Type 2 Diabetes Interventions: Behavioral: Person-centred culturally sensitive course of treatment Sponsors: Steno Diabetes Center Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Prevalence of Diabetic Retinopathy in Type 2 Diabetic Patients
Conditions: Diabetic Retinopathy Interventions: Device: Optical Coherence Tomography (OCT); Device: Fundus fluorescein angiography (FFA) Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Effects of Different'' Exercise Snacking'' Modalities on Glycemic Control in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight or Obesity Interventions: Behavioral: HIIT snacks; Behavioral: Sprint snacks; Other: Control Sponsors: University of Nis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Conditions: Glucose Metabolism Disorders; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Empagliflozin Interventions: Drug: Empagliflozin 10 MG; Drug: Insulin+Metformin+DPP4 inhibitor (DPP4I) Sponsors: SINA Health Education and Welfare Trust; Horizon Pharmaceutical Pvt Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
Conditions: Type 2 Diabetes Interventions: Behavioral: AR group: aerobic training before resistance training; Behavioral: RA group: resistance exercise before aerobic exercise Sponsors: Zhejiang University; Nanjing Sport Institute; Karolinska Institutet Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Polypill for Prevention of Cardiomyopathy
Conditions: Type 2 Diabetes; High Blood Pressure Interventions: Drug: Polypill Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: SGLT2 inhibitor Sponsors: Jeil Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome Interventions: Other: Dietary macronutrient composition Sponsors: Hvidovre University Hospital; University of Copenhagen; Danish Research Centre for Magnetic Resonance Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: AP026 (TQA2226) for injection; Drug: AP026 (TQA2226) for injection matching placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
A Pilot Study to Test the Diabetes Staging System (DSS) in Patient Aligned CareTeams (PACT) Teams
Conditions: Diabetes Mellitus; Type 2 Diabetes Interventions: Other: Diabetes Staging System (DSS) use among Primary Care Teams Sponsors: Durham VA Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: administration of UI068; Drug: administration of UIC202205, UIC202206 Sponsors: Korea United Pharm. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
